Summit Therapeutics Vs. Exelixis Industry Stock Comparison

Sell

31

SMMT
Summit Therapeutics

Last Price:

$17.89

Seasonality Move:

18.6%

Buy

72

EXEL
Exelixis

Last Price:

$33.29

Seasonality Move:

4.86%

Sell

31

Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

The current Summit Therapeutics [SMMT] share price is $17.87. The Score for SMMT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

72

Exelixis (EXEL) is a Buy

Is Exelixis a Buy, Sell or Hold?

The current Exelixis [EXEL] share price is $33.29. The Score for EXEL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
EXEL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

The Summit Therapeutics share price today is $17.87

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

EXEL Stock Price Chart

What is Exelixis's stock price today?

The Exelixis share price today is $33.29

The current trend is moderately bearish and EXEL is experiencing slight selling pressure.

SMMT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.4	Sell
Relative Strength Index (14 RSI):	45.88	Sell
Chaikin Money Flow:	-4547899	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(17.79 - 19.07)	Sell
Bollinger Bands (100):	(13.59 - 22.67)	Sell

EXEL Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.09	Buy
Relative Strength Index (14 RSI):	40.46	Sell
Chaikin Money Flow:	-2514109	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(34.32 - 36.04)	Sell
Bollinger Bands (100):	(25.29 - 33.97)	Buy

SMMT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	18.12	Sell
20-day SMA:	18.32	Sell
50-day SMA:	19.47	Sell
200-day SMA:	12.04	Buy
8-day EMA:	18.07	Sell
20-day EMA:	18.39	Sell
50-day EMA:	18.72	Sell
200-day EMA:	13.66	Buy

EXEL Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	34.63	Sell
20-day SMA:	35.34	Sell
50-day SMA:	33.24	Buy
200-day SMA:	26.02	Buy
8-day EMA:	34.37	Sell
20-day EMA:	34.73	Sell
50-day EMA:	33.15	Buy
200-day EMA:	27.48	Buy

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.

Exelixis Earnings Growth & EXEL Earnings Dates

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $0.05 per share.

Summit Therapeutics Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Exelixis Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):